1.
Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
by Xu, Xin
Nature medicine, 2020, Vol.26 (8), p.1193-1195
2.
A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with...
by Park, Won
Annals of the rheumatic diseases, 2013, Vol.72 (10), p.1605-1612
3.
Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity
by Francis, James N., PhD
Journal of allergy and clinical immunology, 2008, Vol.121 (5), p.1120-1125.e2
4.
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
by Long, Quan-Xin
Nature medicine, 2020, Vol.26 (8), p.1200-1204
5.
Antibody responses to SARS-CoV-2 in patients with COVID-19
by Long, Quan-Xin
Nature medicine, 2020, Vol.26 (6), p.845-848
6.
Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface
by Lewis, Steven M
Nature biotechnology, 2014, Vol.32 (2), p.191-198
7.
The diagnostic utility of serum IgG4 concentrations in IgG4-related disease
by Carruthers, Mollie N
Annals of the rheumatic diseases, 2015, Vol.74 (1), p.14-18
8.
High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire
by DeKosky, Brandon J
Nature biotechnology, 2013, Vol.31 (2), p.166-169
9.
Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase δ syndrome
by Kracker, Sven, PhD
Journal of allergy and clinical immunology, 2014, Vol.134 (1), p.233-236.e3
10.
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexat...
by Yoo, Dae Hyun
Annals of the rheumatic diseases, 2013, Vol.72 (10), p.1613-1620
11.
12.
Dietary baked egg accelerates resolution of egg allergy in children
by Leonard, Stephanie A., MD
Journal of allergy and clinical immunology, 2012, Vol.130 (2), p.473-480.e1
13.
Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy
by Flinterman, Annebeth E., MD
Journal of allergy and clinical immunology, 2008, Vol.121 (3), p.737-743.e10
14.
Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: Complete protection of rhesus monkeys from mucosal SHIV challenge
by Sholukh, Anton M
Vaccine, 2015, Vol.33 (17), p.2086-2095
15.
Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens
by Vickery, Brian P., MD
Journal of allergy and clinical immunology, 2012, Vol.131 (1), p.128-134.e3
16.
IgG4-related disease
by Kamisawa, Terumi, Dr
The Lancet (British edition), 2015, Vol.385 (9976), p.1460-1471
17.
NMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic
by Prestegard, James H
Nature chemical biology, 2011, Vol.7 (3), p.147-153
18.
Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo
by Labrijn, Aran F
Nature biotechnology, 2009, Vol.27 (8), p.767-771
19.
TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes
by Martinez-Gallo, Monica, PhD
Journal of allergy and clinical immunology, 2012, Vol.131 (2), p.468-476
20.
Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations
by Wallace, Zachary S
Annals of the rheumatic diseases, 2015, Vol.74 (1), p.190-195
